Mercedes Kweh
Chief Executive Officer & Co-Founder KweHealth
Dr. Mercedes Kweh is Co-Founder and Chief Executive Officer of KweHealth, a translational platform company building the foundational infrastructure for Acellular, Derived, and Defined Secretome-Based (ADDSB) biologics. She leads the integration of biological discovery, analytical characterization, and clinical translation into a unified system designed to define and scale next-generation therapeutics. Her work focuses on establishing the tools, standards, and regulatory pathways required to advance exosome and secretome-based therapies into clinical reality. Dr. Kweh is actively engaged in shaping the emerging ADDSB field through strategic partnerships across academic, clinical, and global industry ecosystems.
Seminars
- Evaluating exosome dosing strategies: concentrations, delivery methods, and clinical outcomes across multiple conditions
- Understanding Why FDA drug approval models don’t fit acellular biologics — and how the ADDSB framework offers a risk-proportional alternative
- Honing state-level exosome regulation trends and the legislative gap excluding acellular products despite their safety profile and signalling role
